Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Health Economics|February 22, 2023
Selective referral or learning by doing? An analysis of hospital volume-outcome relationship of vascular proceduresJakub ČervenýJournal of Health Economics|September 27, 2025
Financial incentives and COVID-19 vaccinations: Evidence from a conditional cash transfer programJakub Červený, Tomáš Hellebrandt, Peter KravecThe European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 18, 2024
Long-term returns to local health-care spendingJakub Červený, Jan C van OursThe International Journal on Drug Policy|April 11, 2017
Cannabis decriminalization and the age of onset of cannabis useJakub Červený, Pavla Chomynová, Viktor Mravčík, et al.Molecules (Basel, Switzerland)|May 27, 2023
Oligosaccharide Ligands of Galectin-4 and Its Subunits: Multivalency Scores HighlyKristýna Slámová, Jakub Červený, Zuzana Mészáros, et al.Bioorganic Chemistry|February 23, 2024
Glycomimetic inhibitors of tandem-repeat galectins: Simple and efficientDavid Vrbata, Jakub Červený, Natalia Kulik, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|May 6, 2020
Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin InhibitorsTomáš Vašíček, Vojtěch Spiwok, Jakub Červený, et al.Bioorganic Chemistry|November 29, 2022
Advanced high-affinity glycoconjugate ligands of galectinsMichaela Hovorková, Jakub Červený, Ladislav Bumba, et al.Bioorganic Chemistry|May 5, 2024
Synthesis and unexpected binding of monofluorinated N,N'-diacetylchitobiose and LacdiNAc to wheat germ agglutininMartin Kurfiřt, Vojtěch Hamala, Jan Beránek, et al.Journal of Medicinal Chemistry|June 3, 2024
Glycopolymer Inhibitors of Galectin-3 Suppress the Markers of Tissue Remodeling in Pulmonary HypertensionAntonín Sedlář, David Vrbata, Kateřina Pokorná, et al.Pageof 2